News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

PARI Partner Project News

Partner Project News

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

PARI Publication

PARI Publication

A Novel Human Factors Approach for a New Platform-Based, Breath-Triggered Nebuliser

Published

March 17, 2010

Categories

PARI Publications
Publications

Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.

Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.

Published

February 1, 2009

Category

Publications

Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation.

Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation.

Published

September 1, 2006

Categories

PARI Publications
Publications

New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.

New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.

Published

May 12, 2005

Category

PARI Publications

The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.

The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.

Contact us

eFlow-partneringpari.com

Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

PARI Business Development Team